A Safety Study of LY2886721 Multiple Doses in Healthy Subjects

Completed · Phase 1 · Has a placebo group

Conditions studied: Alzheimer's Disease

In brief

This is a Phase 1 study in healthy subjects to evaluate the safety and tolerability of LY2886721 multiple doses, how the body handles the drug, and the drug's effect on the body.

Key facts

Study ID

NCT01227252

Run by

Eli Lilly and Company

People needed

42

Starts

2010-12-01

Expected to finish

2011-04-01

Last updated by the study team

2019-07-19

Who can join

Age: 20 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy men and non-childbearing potential women
• Body mass index between 18.0-32.0 kilograms per square meter (kg/m\^2)
• Are reliable and willing to make yourself available for the duration of the study and are willing to follow study procedures and research unit policies

You may not qualify if…

• Taking over-the-counter or prescription medication with the exception of vitamins or minerals
• Smoke more than 10 cigarettes per day
• Drink more than 5 cups of caffeine containing beverages (for example, coffee, tea) per day

Where it is running

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Glendale, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.